Hypertensive disease
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Transient Ischemic Attack
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Encephalomalacia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hemiparesis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Oculomotor Nerve Paralysis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dissection of aorta
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Aneurysm of aortic root
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of brainstem morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Saccular Aneurysm
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Visual field defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Abnormal circle of Willis morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anorexia Nervosa
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ANGPTL6 levels of AN patients were increased relative to the control group (68.6 ± 9.9 ng/ml) and decreased from 110.2 ± 13.3 to 73.6 ± 7.1 ng/ml (p = 0.004) after partial realimentation.
|
27135654 |
2017 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
AGF support tumor growth and progression.
|
27419371 |
2017 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
ANGPTL6 promotes endothelial cell migration and tube formation, Moreover, ANGPTL6 knockdown inhibits cancer cell apoptosis and invasiveness.
|
31146977 |
2019 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
ANGPTL6 promotes endothelial cell migration and tube formation, Moreover, ANGPTL6 knockdown inhibits cancer cell apoptosis and invasiveness.
|
31146977 |
2019 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
ANGPTL6 loss results in tumor growth in vivo.
|
31146977 |
2019 |
Thyroid stimulating hormone measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide association study identifies protein quantitative trait loci (pQTLs).
|
18464913 |
2008 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
Addition of exogenous miRNA-128 to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' ARP5 (ANGPTL6), Bmi-1 and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines.
|
19941032 |
2010 |
Diabetes Mellitus
|
0.020 |
Biomarker
|
group |
BEFREE |
Although the physiologic functions of human AGF have not yet been identified, serum levels of AGF displayed up-regulation in groups with diseases including preeclampsia and diabetes; and there was little association between genetic variability of AGF and metabolic syndrome-related phenotypes.
|
20673930 |
2011 |
Diabetes
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although the physiologic functions of human AGF have not yet been identified, serum levels of AGF displayed up-regulation in groups with diseases including preeclampsia and diabetes; and there was little association between genetic variability of AGF and metabolic syndrome-related phenotypes.
|
20673930 |
2011 |
Intracranial Aneurysm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Altogether, our results indicate that rare coding variants in ANGPTL6 are causally related to familial forms of IA.
|
29304371 |
2018 |
Limb ischemia
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Among LEPAD patients, those with critical limb ischemia (n=43) showed higher AGF levels (124.9±73.9 vs. 88.98±53.26ng/mL, P=0.01) compared with those with intermittent claudication (n=62).
|
27866700 |
2017 |